EDSA Announces 2025 Catalyst Award Honorees, Celebrating ‘Progress Through Partnership’ in Strengthening Drug Supply Resilience

EDSA Announces 2025 Catalyst Award Honorees, Celebrating ‘Progress Through Partnership’ in Strengthening Drug Supply Resilience

Congratulations to Project PROTECT, recently honored with the 2025 EDSA Catalyst Award for Outstanding Industry Collaboration from the End Drug Shortages Alliance. This award honors a multi-stakeholder partnership that has measurably improved drug access and strengthened supply resilience through cooperation, transparency, and innovation.

This award is especially meaningful because it reflects what Project PROTECT was built on from the very beginning: collaboration, ingenuity, and a shared commitment to protecting patients from essential medicine shortages. Together, Angels for Change, STAQ Pharma, and the Children’s Hospital Association designed and launched a model that brings hospitals, advocacy groups, manufacturers, and supply chain experts around one table to strengthen the stability of the drug supply chain. 

A4C Featured in WJLA Investigation: Bad Drugs or No Drugs

A4C Featured in WJLA Investigation: Bad Drugs or No Drugs

A new WJLA Team investigation exposes how foreign-made chemotherapy drugs are failing quality tests or disappearing from hospitals — leaving patients without safe treatment options. The story features Angels for Change and Founder Laura Bray, whose experience navigating drug shortages during her daughter Abby’s cancer treatment inspired our mission to protect patients and end drug shortages nationwide.

EDSA Advances Shared Mission to End Drug Shortages with 100+ Members

EDSA Advances Shared Mission to End Drug Shortages with 100+ Members

The End Drug Shortages Alliance (EDSA), co-founded by Angels for Change and Vizient, has grown to more than 100 members across the healthcare supply chain. The article highlights how this expanding organization is advancing transparency, data-sharing and coordinated action to strengthen access to essential medicines. Recent progress includes a pilot with children’s hospitals and distributors focused on improving visibility for critical pediatric oncology drugs. The alliance’s continued growth reflects a shared commitment to building a more resilient, patient-centered supply chain.

Senate Passes NDAA with Key MAPS Act Provisions to Strengthen Drug Supply

Senate Passes NDAA with Key MAPS Act Provisions to Strengthen Drug Supply

Angels for Change celebrates the Senate’s passage of the National Defense Authorization Act (NDAA), which includes key provisions from the MAPS Act to strengthen transparency and coordination across the drug supply chain. This bipartisan step, led by Senators Peters, Lankford, Ernst, Cotton, Kaine, King, and Scott, advances meaningful progress toward a more reliable supply of essential medicines.

As the bill moves to the House, Angels for Change urges continued momentum to protect patients and prevent future drug shortages.

Project PROTECT Milestone to Strengthen U.S. Supply of Magnesium Sulfate

Project PROTECT Milestone to Strengthen U.S. Supply of Magnesium Sulfate

Angels for Change’s Project PROTECT has taken a significant step to strengthen preparedness for a lifesaving medicine, magnesium sulfate. In partnership with STAQ Pharma, magnesium sulfate is now ready for on-demand production, reinforcing resilience for a medicine essential to protecting mothers and newborns during emergencies and supply strain. This proactive readiness ensures patients receive vital treatment without delay.

Ensuring Access to Medicines for Every Child

Ensuring Access to Medicines for Every Child

When a child is told the medicine they need to live isn’t available — we must act for change. The Children’s Hospital Association’s new article, “Ensuring Access to Critical Medicines for Children,” shines a light on the shared effort to protect pediatric patients from drug shortages and features Angels for Change’s work to strengthen medicine access nationwide.